Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Dragonfly Therapeutics announces the expansion of its strategic collaboration with Celgene

Thursday, November 15, 2018

Dragonfly Therapeutics Inc today announced that it has entered into an agreement with Celgene Corporation and its subsidiaries Celgene to research Development and commercialization of innovative immunotherapies for patients with solid and hematological cancers The new agreement builds on Celgene39s ..

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Thursday, November 15, 2018

Grnenthal announced today that it has acquired the USbased pharmaceutical company Averitas Pharma thereby extending its commercial footprint to the United States Averitas Pharma will be commercialising the pain patch Qutenza 8 capsaicin for Grnenthal in the US Grnenthal had only recently acquired t..

Enable Injections Enters into Strategic Partnerships with UCB and Apellis Pharmaceuticals

Wednesday, November 14, 2018

Enable Injections Inc a patientcentric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of highvolume therapeutics today announced it has entered into development agreements with Apellis Pharmaceuticals and most recently UCB Enable Injections c..

Ferring Pharmaceuticals Enters Exclusive Agreement with INVO Bioscience

Wednesday, November 14, 2018

Ferring Pharmaceuticals announced today that it has signed an agreement to acquire from INVO Bioscience Inc the exclusive US commercialization rights for the INVOcell intravaginal culture IVC system which comprises the INVOcell IVC device retention device and holding block The INVOcell IVC device us..

Ziopharm Oncology Announces Immuno-oncology Clinical Supply Agreement with Regeneron

Tuesday, November 13, 2018

Ziopharm Oncology Inctoday announced a clinical supply agreement with Regeneron Pharmaceuticals Inc to evaluate Ziopharms AdRTShIL12 plus veledimex in combination with Regenerons PD1 antibody Libtayo cemiplimabrwlc to treat patients with recurrent glioblastoma rGBM AdRTShIL12 plus veledimex is an in..

BridgeBio Pharma LLC Signs Joint Collaboration Agreement with Cincinnati Children's to Accelerate Development of Genetic Disease Therapeutics

Tuesday, November 13, 2018

BridgeBio Pharma LLC and Cincinnati Children39s Hospital Medical Center today announced they are entering into a research collaboration to identify and develop genetic disease therapies This partnership will combine BridgeBio39s strengths in therapeutic development for diseases of high unmet need wi..

Strides enters into strategic partnership with SUDA Pharmaceuticals for the US market

Monday, November 12, 2018

Strides Pharma Science Limited Strides has announced that its stepdown wholly owned subsidiary Strides Pharma Global Pte Limited Singapore has entered into an exclusive product development licensing and supply agreement with SUDA Pharmaceuticals Ltd for its novel drug SUD0001H an oral spray of sumat..

Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio

Friday, November 09, 2018

Vectura Group plc today announces signing an agreement with Hikma Pharmaceuticals PLC Hikma for the global development and commercialisation of generic versions of GSKs Ellipta portfolio utilising Vecturas proprietary OpenInhaleClose dry powder inhaler device Following interactions with US FDA th..

BioTime and Asterias Biotherapeutics Enter Into Definitive Merger Agreement to Create Leading Cell Therapy Company

Friday, November 09, 2018

BioTime Inc and Asterias Biotherapeutics Inc today announced that they have entered into a definitive merger agreement whereby BioTime will acquire all of the remaining outstanding common stock of Asterias that are not currently owned by BioTime Asterias stockholders will receive 071 shares of BioTi..

Guided Therapeutics Announces Extension of Distribution Agreement for Eastern Europe and Russia

Friday, November 09, 2018

Guided Therapeutics Inc the maker of a rapid and painless testing platform based on its patented biophotonic technology today announced it has signed an extension of its distribution agreement with its Russian and Eastern European Sales and Marketing partner Newmars Group Kft The contract extensi..